Informação sobre produto
- Luxalbendazole
- methyl N-[5-(4-fluorophenyl)sulfonyloxy-3H-benzoimidazol-2-yl]carbamate
- 2-[(methoxycarbonyl)amino]-1H-benzimidazol-6-yl 4-fluorobenzenesulfonate
Luxabendazole is a benzimidazole compound that is used to treat parasitic worm infections. It works by inhibiting the activity of glutamate dehydrogenase and aminotransferases, which are enzymes that catalyze the metabolic pathways for amino acids. Luxabendazole has been shown to be effective in vivo against cancer cells, and it has been shown to inhibit the growth of tumor cells through its inhibition of glutamine synthetase and glutamate synthase. Luxabendazole can be administered orally or by injection. The elimination rate is rapid with a half-life of 2 hours. The effective dose is between 10-20 mg/kg body weight per day, with treatment lasting 7-14 days.
Propriedades químicas
Consulta técnica sobre: 3D-FL100571 Luxabendazole
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
